Daniel M. Watterson
Affiliations: | Integrated Graduate Program in the Life Sciences | Northwestern University, Evanston, IL |
Area:
Biochemistry, General BiophysicsGoogle:
"Daniel Watterson"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Laurie K. McNamara | grad student | 2009 | Northwestern |
| Adam D. Bachstetter | post-doc | 2009-2010 | (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Falcicchia C, Tozzi F, Arancio O, et al. (2020) Involvement of p38 MAPK in Synaptic Function and Dysfunction. International Journal of Molecular Sciences. 21 |
| Roy SM, Minasov G, Arancio O, et al. (2020) Correction to "A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction". Journal of Medicinal Chemistry |
| Roy SM, Minasov G, Arancio O, et al. (2019) A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction. Journal of Medicinal Chemistry |
| Bailey A, Suri A, Tavares M, et al. (2019) THER-09. EVALUATION OF PROTEIN KINASE INHIBITORS WITH PLK4 CROSS-OVER POTENTIAL IN PEDIATRIC EMBRYONAL BRAIN TUMORS Neuro-Oncology. 21: ii115-ii116 |
| Rutigliano G, Stazi M, Arancio O, et al. (2018) An isoform-selective p38α mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer's disease. Neurobiology of Aging. 70: 86-91 |
| Sredni ST, Bailey AW, Suri A, et al. (2017) Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma. Oncotarget. 8: 111190-111212 |
| Zhou Z, Bachstetter AD, Späni CB, et al. (2017) Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes. Journal of Neuroinflammation. 14: 75 |
| Maphis N, Jiang S, Xu G, et al. (2016) Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology. Alzheimer's Research & Therapy. 8: 54 |
| Bachstetter AD, Zhou Z, Rowe RK, et al. (2016) MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses. Plos One. 11: e0149451 |
| Van Eldik LJ, Zhou Z, Watterson DM, et al. (2016) P2-129: A Small Molecule Anti-Neuroinflammatory Experimental Therapeutic Inhibited IL-1Beta Levels After Traumatic Brain Injury with no Effect on Microglia Physiological Responses Alzheimer's & Dementia. 12: P661-P661 |